|
|
Volumn 8, Issue 13, 2001, Pages 1535-1542
|
|
Presents trend and future strategy in chemotherapy of malaria+
|
|
Author keywords
Antimalarial drugs; Biochemical target sites; Chemotherapy; Drug design
|
|
Indexed keywords
ACRIDINE DERIVATIVE;
AMIDINE;
AMINOQUINOLINE DERIVATIVE;
AMODIAQUINE;
AMOPYROQUINE;
ANTIBIOTIC AGENT;
ANTIMALARIAL AGENT;
CHLOROPROGUANIL;
CHLOROQUINE;
CYCLOGUANIL;
CYCLOQUINE;
DNA TOPOISOMERASE;
DOXYCYCLINE;
GUANIDINE DERIVATIVE;
LACTONE DERIVATIVE;
MAFLOQUINE;
POLYAMINE DERIVATIVE;
PRIMAQUINE;
PYRIMETHAMINE;
PYRIMIDINE DERIVATIVE;
QUINOCIDE;
QUINOLONE DERIVATIVE;
SULFADIAZINE;
SULFADOXINE;
SULFALENE;
SULFONAMIDE;
SULFONE DERIVATIVE;
TETRACYCLINE;
TRIMETHOPRIM;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTIINFECTIVE AGENT;
MEPACRINE;
ARTICLE;
CHEMOTHERAPY;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG STRUCTURE;
FOLATE METABOLISM;
MALARIA;
PYRIMIDINE METABOLISM;
REVIEW;
ANIMAL;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
METABOLISM;
PLASMODIUM FALCIPARUM;
ANIMALS;
ANTI-BACTERIAL AGENTS;
ANTIMALARIALS;
DNA TOPOISOMERASES;
HUMANS;
MALARIA;
PLASMODIUM FALCIPARUM;
PYRIMIDINES;
QUINACRINE;
SULFONAMIDES;
|
|
EID: 0034746828
PISSN: 09298673
EISSN: None
Source Type: Journal
DOI: 10.2174/0929867013371851 Document Type: Article |
|
Times cited : (183)
|
|
References (40)
|
